Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Uveal Melanoma × Polyethylene Glycols × Gynecologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1 Dermatologic 1

Conditions

Uveal Melanoma 1 Ovarian Neoplasms 1 Melanoma 1

Interventions

utomilumab 1 entinostat 1 cemiplimab 1 Thrombopoietin 1 Polyethylene Glycols 1 Nivolumab 1 Immunologic Techniques 1 Ifosfamide 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Etoposide 1 Cyclophosphamide 1 Carboplatin 1 Bevacizumab 1 ADI PEG20 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01665183 2016-02-25

Ph 1 Trial of ADI-PEG 20 Plus Cisplatin in Patients With Metastatic Melanoma

Polaris Group

Phase 1 Completed

DermatologicGynecologic

Uveal Melanoma, Melanoma, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡